234 related articles for article (PubMed ID: 30166701)
1. NEW STRATEGIES TO PREDICT AND PREVENT SERIOUS IMMUNOLOGICALLY MEDIATED ADVERSE DRUG REACTIONS.
Phillips EJ
Trans Am Clin Climatol Assoc; 2018; 129():74-87. PubMed ID: 30166701
[TBL] [Abstract][Full Text] [Related]
2. Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response.
Yun J; Mattsson J; Schnyder K; Fontana S; Largiadèr CR; Pichler WJ; Yerly D
Clin Exp Allergy; 2013 Nov; 43(11):1246-55. PubMed ID: 24152157
[TBL] [Abstract][Full Text] [Related]
3. Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions.
Karnes JH; Miller MA; White KD; Konvinse KC; Pavlos RK; Redwood AJ; Peter JG; Lehloenya R; Mallal SA; Phillips EJ
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():463-486. PubMed ID: 30134124
[TBL] [Abstract][Full Text] [Related]
4. New approaches for predicting T cell-mediated drug reactions: A role for inducible and potentially preventable autoimmunity.
Michels AW; Ostrov DA
J Allergy Clin Immunol; 2015 Aug; 136(2):252-7. PubMed ID: 26254052
[TBL] [Abstract][Full Text] [Related]
5. Drug Hypersensitivity: How Drugs Stimulate T Cells via Pharmacological Interaction with Immune Receptors.
Pichler WJ; Adam J; Watkins S; Wuillemin N; Yun J; Yerly D
Int Arch Allergy Immunol; 2015; 168(1):13-24. PubMed ID: 26524432
[TBL] [Abstract][Full Text] [Related]
6. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
Ko TM; Chung WH; Wei CY; Shih HY; Chen JK; Lin CH; Chen YT; Hung SI
J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigens and drug hypersensitivity.
Chung WH; Hung SI; Chen YT
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics of hypersensitivity drug reactions.
Negrini S; Becquemont L
Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
[TBL] [Abstract][Full Text] [Related]
9. A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity.
Cardone M; Garcia K; Tilahun ME; Boyd LF; Gebreyohannes S; Yano M; Roderiquez G; Akue AD; Juengst L; Mattson E; Ananthula S; Natarajan K; Puig M; Margulies DH; Norcross MA
J Clin Invest; 2018 Jul; 128(7):2819-2832. PubMed ID: 29782330
[TBL] [Abstract][Full Text] [Related]
10. Human Leukocyte Antigen Associations in Drug Hypersensitivity Reactions.
Schutte RJ; Sun Y; Li D; Zhang F; Ostrov DA
Clin Lab Med; 2018 Dec; 38(4):669-677. PubMed ID: 30420060
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics of allopurinol--making an old drug safer.
Lam MP; Yeung CK; Cheung BM
J Clin Pharmacol; 2013 Jul; 53(7):675-9. PubMed ID: 23381951
[TBL] [Abstract][Full Text] [Related]
12. Immune pathomechanism of drug hypersensitivity reactions.
Pichler WJ; Naisbitt DJ; Park BK
J Allergy Clin Immunol; 2011 Mar; 127(3 Suppl):S74-81. PubMed ID: 21354503
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics of off-target adverse drug reactions.
Garon SL; Pavlos RK; White KD; Brown NJ; Stone CA; Phillips EJ
Br J Clin Pharmacol; 2017 Sep; 83(9):1896-1911. PubMed ID: 28345177
[TBL] [Abstract][Full Text] [Related]
14. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
Bharadwaj M; Illing P; Theodossis A; Purcell AW; Rossjohn J; McCluskey J
Annu Rev Pharmacol Toxicol; 2012; 52():401-31. PubMed ID: 22017685
[TBL] [Abstract][Full Text] [Related]
15. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.
White KD; Chung WH; Hung SI; Mallal S; Phillips EJ
J Allergy Clin Immunol; 2015 Aug; 136(2):219-34; quiz 235. PubMed ID: 26254049
[TBL] [Abstract][Full Text] [Related]
16. Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions.
Wang CW; Dao RL; Chung WH
Curr Opin Allergy Clin Immunol; 2016 Aug; 16(4):339-45. PubMed ID: 27362322
[TBL] [Abstract][Full Text] [Related]
17. HLAs: Key regulators of T-cell-mediated drug hypersensitivity.
Redwood AJ; Pavlos RK; White KD; Phillips EJ
HLA; 2018 Jan; 91(1):3-16. PubMed ID: 29171940
[TBL] [Abstract][Full Text] [Related]
18. Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.
Yip VL; Alfirevic A; Pirmohamed M
Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):165-75. PubMed ID: 24777842
[TBL] [Abstract][Full Text] [Related]
19. Genetics and the potential for predictive tests in adverse drug reactions.
Pirmohamed M
Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
[TBL] [Abstract][Full Text] [Related]
20. Detection of Primary T Cell Responses to Drugs and Chemicals in HLA-Typed Volunteers: Implications for the Prediction of Drug Immunogenicity.
Faulkner L; Gibson A; Sullivan A; Tailor A; Usui T; Alfirevic A; Pirmohamed M; Naisbitt DJ; Kevin Park B
Toxicol Sci; 2016 Dec; 154(2):416-429. PubMed ID: 27637899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
